Aseptic manufacturing of regenerative medicine products using isolator technology
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Isolator-based technologies have revolutionized aseptic processing over the past two decades by separating human operators from the production environment, reducing contamination risks and enabling safe manufacture of heat-labile or sensitive biological products.
“Indeed, isolator-based technologies have revolutionized aseptic processing over the past two decades by effectively separating human operators from the production environment, thereby dramatically reducing contamination risks and enabling the safe manufacture of heat-labile or sensitive biological products (Kokubo et al., 2016).”
From Isolator-based point-of-care manufacturing: a practical solution for GMP-compliant cell and extracellular vesicles therapy production (2025) · cites this paper as Kokubo et al., 2016
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726 · see citing works
Blum, H. E. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.04.005 · Cited by 241 · see citing works
Watling, D., Ryle, C., Parks, M., & Christopher, M. (2002) · PubMed · Cited by 41 · see citing works
Ljungqvist, B., & Reinmüller, B. (2000) · PubMed · Cited by 14 · see citing works
Stem Cell Research and Regenerative Medicine in 2014: First Year of Regenerative Medicine in Japan
Okano, H. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0200 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Chiu, Y.-S., Wang, K.-L., & Wu, K.-L. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1644318 · Cited by 17 · see citing works
Mathew, R., McGee, R., Roche, K. J., Warreth, S., & Papakostas, N. (2022) · Applied Sciences · doi:10.3390/app122110895 · Cited by 12 · see citing works
- Authors
- Kokubo, M., & Akers, J. E.
- Affiliations
- Shibuya (Japan) (JP)
- Corresponding author
- Akers, James E.
- Venue
- Gene Therapy and Cell Therapy Through the Liver
- Publisher
- Springer Japan
- Published
- 2016
- Pages
- 149-170
- OpenAlex
- W2295879391
- Cited by
- 2
- References
- 5
- Citations by year
- 2025: 1 · 2022: 1
- FWCI
- 0.00
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- Locations
- Springer eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Health Sciences › Health Professions › Occupational Therapy › Safe Handling of Antineoplastic Drugs
- Keywords
- aseptic processing, regenerative medicine products, microbial contamination prevention, robotics in manufacturing, machine automation, patient safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
